Stay updated on RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.

Latest updates to the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedThere are no textual changes detected for this study page. The content appears unchanged.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a minor update to the page's version metadata without altering the study content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the ClinicalTrials.gov entry without altering the study data. The study data and eligibility information appear unchanged.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of Revision: v3.6.0, indicating a small update to the page build rather than any substantive changes to the study details.SummaryDifference0.0%

- Check57 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', signaling that enrollment has ended. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study), adjusts the Intervention/Treatment label, and updates the revision footer to v3.6.0.SummaryDifference0.4%

- Check64 days agoChange DetectedThe page's revision tag has been updated to v3.5.5, replacing the previous v3.5.4. This change reflects a backend revision update and does not modify the study information displayed on the page.SummaryDifference0.0%

Stay in the know with updates to RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.